WHO ICTRP trial
PLUTO - Prevention of CKD progression in type 1 diabetes with Long term Use of…
CTIS2023-509450-55-01 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2023-509450-55-01 |
|---|---|
| Public title | PLUTO - Prevention of CKD progression in type 1 diabetes with Long term Use of SGLTi avoiding kidney hypOxia |
| Scientific title | Prevention of CKD progression in type 1 diabetes with Long term Use of SGLTi avoiding kidney hypOxia (PLUTO) |
| Primary sponsor | Steno Diabetes Center Copenhagen |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | United Kingdom;Denmark |
| Conditions | Type 1 Diabetes Mellitus with chronic kidney complications;Therapeutic area: Phenomena and Processes [G] - Metabolism [G03];Therapeutic area: Diseases [C] - Hormonal diseases [C19];Therapeutic area: Diseases [C] - Nutritional and Metabolic… |
| Interventions | Product Name: PLACEBO PRODUCT [PLACEBO MATCHING SOTAGLIFLOZIN 200 MG FILM-COATED TABLETS], Product Code:N/A, Pharmaceutical Form: N/A, Other descriptive name: N/A , Strength: , Pharmaceutical form of the placebo: N/A , Product Name… |
| Registration date | May 13, 2024 |
| Target size | 69 |
| Secondary IDs | NCT06147232 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: